Ex vivo expansion of CD34+ and T and NK cells from umbilical cord blood for leukemic BALB/C nude mouse transplantation

International Journal of Hematology

Volumn 87, Issue 2, 2008, Pages 217-224

  Wei, Yaming ^a   Huang, Yinfeng ^a   Zhang, Yinze ^b   Zhou, Huayou ^b   Cao, Qiong ^b   Meng, Qingbao ^b   Lan, Juncai ^b   Chen, Longhua ^b  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cord blood; Expansion; NK cell; Stem cell; Transplantation

Indexed keywords

BCR ABL PROTEIN; CD56 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD34 SELECTION; CELL PROLIFERATION; CHIMERA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FETAL BLOOD; GRAFT VS LEUKEMIA EFFECT; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 42049102627     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0028-0     Document Type: Article

References (28)

1. Wanger J, Rosenthal J, Sweetman R, Shu X, Davies S, Ramsay N, Mcglave P, Sender L, Cairo M. Succsessful transplantation of HLA-mismatched umbilical cord blood from unrelated donors analysis of engraftment and acute graft-versus-host disease. Blood. 1996;88:795-802
2. D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica. 1998;83:197-203
3. + cord blood cell-derived and irradiated tumor cell-primed dendritic cells. Inter J Hematol. 1998;68:169-82
4. Gorin NC, Piantadosi S, Stull M, Bonte H, Wingard JR, Civin C. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. J Hematother Stem Cell Res. 2002;11:277-92
5. van Lochem E, de Gast B, Goulmy E. In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone marrow transplant. 1992;10:181-3
6. Cohen Y, Nagler A. Umbilical cord blood transplantation-how, when and for whom? Blood Rev. 2004;18:167-79
7. + cord blood cells. Blood. 1999;93:1097-1105
8. Ballen K, Becker PS, Greiner D, Valinski H, Shearin D, Berrios V, Dooner G, Hsieh CC, Wuu J, Shultz L, Cerny J, Leif J, Stewart FM, Quesenberry P. Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice. Br J Haematol. 2000;108:629-40
9. Robinson KL, Ayello J, Hughes R, van de Ven C, Issitt L, Kurtzberg J, Cairo MS. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation. Exp Hematol. 2002;30:245-51
10. Robinson S, Niu T, de Lima M, Ng J, Yang H, McMannis J, Karandish S, Sadeghi T, Fu P, del Angel M, O'Connor S, Champlin R, Shpall E. Ex vivo expansion of umbilical cord blood. Cytotherapy. 2005;7:243-50
11. Liu Y, Pei X, Lu S. Studies on hematopoietic reconstitution by ex vivo expanded human cord blood hematopoietic stem/progenitor cells in SCID mice. Chin J Hematol. 1999;20:634-6
12. + cells using the DIDECO "Pluricell System". Bone Marrow Transplant. 2005;35:1101-6
13. Bruno S, Gammaitoni L, Gunetti M, Sanavio F, Fagioli F, Aglietta M, Piacibello W. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model. J Biol Regul Homeost Agents. 2001;15:38-48
14. + T cells. J Hematother. 1999;8:129-39
15. Carayol G, Robin C, Bourhis JH, Bennaceur-Griscelli A, Chouaib S, Coulombel L, Caignard A. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur J Immunol. 1998;28:1991-2002
16. + NK T and gamma delta T cells from cord blood of human neonates. Clin Exp Immunol. 1998;113:220-8
17. Azuma H, Yamada Y, Shibuya-Fujiwara N, Yamaguchi M, Murahashi H, Fujihara M, Sato N, Fukazawa K, Ikebuchi K, Ikeda H. Functional evaluation of ex vivo expanded cord blood lymphocytes: possible use for adoptive cellular immunotherapy. Exp Hematol. 2002;30:346-51
18. Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I, Fichtner I. Sensitive PCR method for the detection and real-time quantification of human cells in xeno transplantation systems. Br J Cancer. 2002;87:1328-35
19. Brugger W, Kanz L. Ex vivo expansion of hematopoietic precursor cells. Curr Opin Hematol. 1996;3:235-40
20. Stefan S, Karsten KA, Bernhard M, Wolfram B, Lothar K. Ex vivo expansion of hematopoietic progenitor cells for clinic use. Semin Hematol. 1998;35:232-40
21. Devine SM, Lazarus HM, Emerson SG. Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplant. 2003;31:241-52
22. Denning-Kendall PA, Evely R, Singha S, Chapman M, Bradley BA, Hows JM. In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells. Br J Haematol. 2002;116:218-28
23. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, Bearman SI, Nieto Y, Freed B, Madinger N, Hogan CJ, Slat-Vasquez V, Russell P, Blunk B, Schissel D, Hild E, Malcolm J, Ward W, McNiece IK. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368-76
24. + cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood. 1999;93:3736-49
25. Novitzky N, Davison GM. Immune reconstitution following hematopoietic stem-cell transplantation. Cytotherapy. 2001;3:211-20
26. Joshi SS, Tarantolo SR, Kuszynski CA, Kessinger A. Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer. Clin Cancer Res. 2000;6:4351-8
27. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, De Coene C, Selz F, Le Deist F, Fischer A. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood. 1996;88:3901-9
28. Wei Yaming, Lin Jihong, Xia Rong, Lan Juncai. Establishment of a BALB/C nude mouse model with bone marrow leukemia. J Exp Hematol. 2005;13(4):590-600